Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase

Bone Marrow Transplantation

Volumn 25, Issue , 2000, Pages S105-S109

  Williams, D A ^a,b   Maze, R ^a   Kurpad, C ^b   Pegg, A ^c   Erickson, L C ^b  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

6 benzylguanine; Chloroethylnitrosoureas; Dna repair; Mgmt; Retrovirus vectors

Indexed keywords

6 O BENZYLGUANINE; CARMUSTINE; CHLOROETHYLNITROSOUREA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

CONFERENCE PAPER; GENE TRANSFER; HEMATOPOIETIC CELL; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CARMUSTINE; DNA REPAIR; DRUG RESISTANCE; GENE EXPRESSION; GENE THERAPY; GUANINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; LEUKEMIA L1210; MICE; MUTATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 0033919655     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702367     Document Type: Article

References (35)

1. 6-guanine position of dGTP. Carcinogenesis 1983; 4: 1591-1597.
2. 6-alkylguanine-DNA alkyltransferase. Prog Nucl Acid Res Mol Biol 1995; 51: 167-223.
3. 6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. Cancer Detect Prev 1996; 20: 130-136.
4. 6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Cancer Res 1998; 58: 1068-1073.
5. 6-alkylguanine-DNA alkytransferase activity in human myeloid cells. J Clin Invest 1985; 76: 2106-2114.
6. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis 1986; 7: 745-749.
7. Moritz T, Mackay W, Glassner BJ et al. Retroviral-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res 1995; 55: 2608-2614.
8. Schabel FM Jr. Nitrosoureas: a review of experimental antitumor activity. Cancer Treat Rep 1976; 60: 665-698.
9. Botnick LE, Hannon EC, Hellman S. Multisystem stem cell failure after apparent recovery from alkylating agents. Cancer Res 1978; 38: 1942-1947.
10. Neben S, Hemman S, Montegomery M et al. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. J Exp Hematol 1993; 21: 156-162.
11. Allay JA, Koc ON, Davis BM, Gerson SL. Retroviralmediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors. Clin Cancer Res 1996; 2: 1353-1359.
12. Allay JA, Davis BM, Gerson SL. Human alkyltransferasetransduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice. Exp Hematol 1997; 25: 1069-1076.
13. 6-alkylguanine-DNA-alkyltransferase. Blood 1996; 87: 1957-1961.
14. Maze R, Carney JP, Kelley MR et al. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc Natl Acad Sci USA 1996; 93: 206-210.
15. 6-methylguanine DNA methyltransferase complementary DNA. J Immunol 1997; 158: 1006-1013.
16. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 1997; 57: 5093-5099.
17. 6-benzylguanine sensitization to chloroethylnitrosourea treatment. J Pharmacol Exp Ther 1999; 291: 1269-1275.
18. Futscher BW, Micetich KC, Barnes DM et al. Inhibition of a specific DNA repair system and nitrosourea cytotoxicity in resistant human cancer cells. Cancer Commun 1989; 1: 65-73.
19. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 1990; 87: 5368-5372.
20. 6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. Cancer Commun 1990; 2: 371-377.
21. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 1991; 51: 3367-3372.
22. 6-benzylguan ine on the sensitivity of human tumor xenografts to 1,3,-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Cancer Res 1992; 52: 1171-1175.
23. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone. Biochem Pharmacol 1993; 45: 483-491.
24. Marathi UK, Dolan ME, Erickson LC. Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo. Biochem Pharmacol 1994; 48: 2127-2134.
25. 6-benzylguanine plus BCNU. Cancer Res 1997; 57: 4817-4823.
26. 6-benzylguanine. Cancer Res 1994; 54: 6221-6227.
27. 6-benzylguanine to killing by n, n9-bis(2-chlorethyl)-nnitrosourea. Cancer Res 1996; 56: 1578-1583.
28. Encell LP, Coates MM, Loeb LA. Engineering human DNA alkyltransferases for gene therapy using random sequence mutagenesis. Cancer Res 1998; 58: 1013-1020.
29. 6-benzylguanine. Cancer Res 1998; 58: 1936-1945.
30. Moritz T, Williams DA. Methods for gene transfer: genetic manipulation of hematopoietic stem cells. In: Donnall TE (ed). Hematopoietic Cell Transplantation. Blackwell Science: Malden, MA, 1998, pp 79-88.
31. 6-alkylguanine-DNA alkyltransferase. Gene Therapy 1996; 3: 868-877.
32. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. J Virol 1988; 167: 400-406.
33. Hanenberg H, Xiao XL, Dilloo D et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med 1996; 2: 876-882.
34. Moritz T, Dutt P, Xiao XL et al. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 1996; 88: 855-862.
35. 6-alkylguanine-DNA alkyltransferase activity in human cells and tumor tissues by restriction endonuclease inhibition. Cancer Res 1987; 47: 6229-6235.